AMPK-IN-3

Research use only, not for human use.

AMPK-IN-3 is a novel, selective and potent AMPK inhibitor with inhibitory effects on AMPK (α2), AMPK (α1) and KDR, with IC50 values of 60.7, 107 and 3820 nM, respectively.AMPK-IN-3 showed anticancer activity in K562 cells.

AMPK-IN-3 (compound 67) is a potent and selective AMPK inhibitor with IC50s of 60.7, 107 and 3820 nM for AMPK (α2), AMPK (α1) and KDR, respectively. AMPK-IN-3 inhibits AMPK does not affect cell viability or cause significant cytotoxicity in K562 cells. AMPK-IN-3 can be used in study of cancer.

AMPK-IN-3 (100 nM) shows inhibition values for AMPK(α2), FLT1, JAK1 JH2-pseudokinase and AMPK(α1) for 64%, 43%, 41% and 29%, respectively.AMPK-IN-3 (0.195313, 0.78125, 3.125, 12.5, 50 μM; 2 h) decreases the level of p-ACC in K562 cells.AMPK-IN-3 (1-100 μM; 24, 48, 72 h) shows potent inhibition of cellular AMPK activity but not affect cell viability.Cell Viability Assay Cell Line:K562 cells Concentration:0.195313, 0.78125, 3.125, 12.5, 50 μM Incubation Time:2 h Result:Decreased cellular levels of p-ACC(Ser79) in K562 cells.Cell Viability Assay Cell Line:K562 cells Concentration:1-100 μM Incubation Time:24, 48, 72 h Result:Showed no measurable impact on cell viability in K562 cells cultured under hypoxic conditions for 72 hours.

——

——

Angiogenesis

VEGFR

VEGFR | AMPK

——

——

2417674-27-0

451.56

C25H33N5O3

>98% (HPLC)

In Vitro:?DMSO : 115 mg/mL (254.67 mM; Ultrasonic )

CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(CCC(N)=O)cc23)c1C

——

(-20℃)

With Ice Pack

≥ 2 years